Biosimilar Monoclonal Antibody Market Analysis Shows Increasing Regulatory Approvals
The global biosimilar monoclonal antibody market is witnessing robust growth, driven by the increasing demand for cost-effective biologic therapies and the rising burden of chronic diseases such as cancer and autoimmune disorders. The market size was valued at USD 10.71 billion in 2024 and is projected to grow from USD 12.44 billion in 2025 to USD 40.77 billion...
0 Comentários 0 Compartilhamentos 81 Visualizações 0 Anterior
Patrocinado
MyLiveRoom https://myliveroom.com